Author

Lorenzo Buroni

Institute of Cancer ResearchORCID 0000-0003-1999-4028Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Johann Sebastian De BonoiD· 2 shared Abigail M. MorrisoniD· 1 shared Adam SharpiD· 1 shared Amanda SwainiD· 1 shared Ana FerreiraiD· 1 shared Andrew C.B. CatoiD· 1 shared Antje NeebiD· 1 shared Bissan Al‐LazikaniiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Johann Sebastian De BonoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Visualized ExperimentsPeer-reviewedJan 5, 2024

Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer

Kaitriana E. Colling, Emily L. Symons, Lorenzo Buroni…·Kristina W. Thiel

The paper describes an automated live-cell imaging method to assess drug responses in patient-derived organoid models, demonstrating its ability to quantify cell health and apoptosis over time.

8 citations

humanimaging

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 17, 2022

Targeting the BAG-1 family of co-chaperones in lethal prostate cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan…·Adam Sharp

This study investigates Thio-2's mechanism of action in inhibiting AR signaling in CRPC, showing it acts independently of BAG-1 isoforms and with potential AR NTD binding.

DOI 10.1101/2022.10.17.512378

humanproteomics

𝕏 PostBluesky